Verge Genomics
Business Services · California, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
2 Tower Pl Ste 950, South San Francisco,...Phone Number
(415) 400-5064Website
www.vergegenomics.comRevenue
$7.4 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
2
2
1
2
1
1
About Verge Genomics
Verge Genomic's mission is to revolutionize the way that drugs are discovered and developed. Verge Genomics was founded in 2015 and is based in California, the United States.Explore more
Verge Genomics Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Verge Genomics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Verge Genomics, which may be a good buyer, showed buying intent in Masked Content Topic
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check out if Verge Genomics is spiking on competitors!
Check if Verge Genomics has recently received funding, and reach out quickly before it becomes old news!
Product Launch: Get notified when Verge Genomics launches new products
Funding: Get notified immidiatlly once Verge Genomics has new funding data
Click to see if Verge Genomics had a recent Job posting/layoffs
Earning: See what the market has to say on Verge Genomics recently announced quarterly report
Congratulate Masked Content for being promoted to Masked Content at Verge Genomics
Website visits: Recent activity has been detected on your website
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find more new buyers
Compare Similar Companies to Verge Genomics
Compare insights from companies similar to Verge Genomics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Verge Genomics is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Verge Genomics is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Verge Genomics.
Verge Genomics financials insights
Gather financial insights about Verge Genomics, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2015
Angel/Seed
$4M
2018
Series A
$32M
2020
Debt
$350K
2021
Series B
$98M
Verge Genomics Tech Stack
A closer look at the technologies used by Verge Genomics
Most Recent Scoops
Person-Based
Speech Recognition, Medical Research
Person-Based
Speech Recognition
Left Company
Executive Move
Diego Cadavid, Chief Medical Officer, has left the organization and now serves as Vice President, Clinical Development at Vertex Pharmaceuticals Inc.
Executive Moves, Left Company
Left Company
Executive Move
Executive Moves, Left Company
Left Company
Executive Move
Executive Moves, Left Company
Verge Genomics News & Media
Verge Genomics and Collaborators Identify Digital Clinical Biomarker Endpoints Sensitive to Short Term Disease Progression in the Pre-treatment Run-in Period of VRG50635 Proof-of-Concept ALS Clinical Trial
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)-- #als--Verge Genomics, a clinical-stage, tech-enabled biotechnology company pioneering the use of artificial intelligence (AI) and human data to transform drug discovery and development, today announced new findings demonstrating that multiple digital clinical biomarker endpoints can capture measurable disease progression during the eight-week, pre-treatment run-in period of the Phase 1b proof-of-concept study of VRG50635, an investigational PIKfyveVerge Genomics Announces Milestones in Collaboration with Lilly to Discover and Develop Novel Treatments for ALS
— Lilly to Develop Two Targets Identified and Validated Using Verge Genomics’ AI-Enabled, All-in-Human CONVERGE® PlatformLeadership with vulnerability powers Verge Genomics CEO: 'Authenticity over fear' | Fortune
“Vulnerability, a key leadership principle, helps me better understand my colleagues,” says Verge Genomics CEO Alice Zhang.Verge Genomics and Ferrer Announce Agreement to Co-Develop Clinical-Stage ALS Therapy VRG50635
SOUTH SAN FRANCISCO & BARCELONA, Spain--(BUSINESS WIRE)--Verge Genomics, a leading clinical-stage biotechnology company, and Ferrer, an international B Corp pharmaceutical company with an increasing focus in rare neurological disorders, have announced a strategic collaboration to co-develop VRG50635, Verge’s lead drug candidate for the treatment of sporadic and familial forms of amyotrophic lateral sclerosis (ALS), in Europe, Central and South America, Southeast Asia and Japan. VRG50635 is a po
Read more news
Top Business Services Companies
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Verge Genomics
Sign Up For FreeTo access detailed company insights
Verge Genomic's mission is to revolutionize the way that drugs are discovered and developed. Verge Genomics was founded in 2015 and is based in California, the United States.... Read More
